A citation-based method for searching scientific literature

Leena Gandhi, Delvys Rodríguez-Abreu, Shirish Gadgeel, Emilio Esteban, Enriqueta Felip, Flávia De Angelis, Manuel Domine, Philip Clingan, Maximilian J Hochmair, Steven F Powell, Susanna Y-S Cheng, Helge G Bischoff, Nir Peled, Francesco Grossi, Ross R Jennens, Martin Reck, Rina Hui, Edward B Garon, Michael Boyer, Belén Rubio-Viqueira, Silvia Novello, Takayasu Kurata, Jhanelle E Gray, John Vida, Ziwen Wei, Jing Yang, Harry Raftopoulos, M Catherine Pietanza, Marina C Garassino. N Engl J Med 2018
Times Cited: 2818



Hossein Borghaei, Luis Paz-Ares, Leora Horn, David R Spigel, Martin Steins, Neal E Ready, Laura Q Chow, Everett E Vokes, Enriqueta Felip, Esther Holgado, Fabrice Barlesi, Martin Kohlhäufl, Oscar Arrieta, Marco Angelo Burgio, Jérôme Fayette, Hervé Lena, Elena Poddubskaya, David E Gerber, Scott N Gettinger, Charles M Rudin, Naiyer Rizvi, Lucio Crinò, George R Blumenschein, Scott J Antonia, Cécile Dorange, Christopher T Harbison, Friedrich Graf Finckenstein, Julie R Brahmer. N Engl J Med 2015
Times Cited: 5872




List of shared articles



Times cited

First-in-Humans Evaluation of a PD-L1-Binding Peptide PET Radiotracer in Non-Small Cell Lung Cancer Patients.
Xin Zhou, Jinquan Jiang, Xue Yang, Teli Liu, Jin Ding, Sridhar Nimmagadda, Martin G Pomper, Hua Zhu, Jun Zhao, Zhi Yang,[...]. J Nucl Med 2022
6

Tumor Immunology and Immunotherapy of Non-Small-Cell Lung Cancer.
Tina Cascone, Jared Fradette, Monika Pradhan, Don L Gibbons. Cold Spring Harb Perspect Med 2022
1

Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition.
Marcus Unterrainer, Julian Taugner, Lukas Käsmann, Amanda Tufman, Niels Reinmuth, Minglun Li, Lena M Mittlmeier, Peter Bartenstein, Wolfgang G Kunz, Jens Ricke,[...]. Eur J Nucl Med Mol Imaging 2022
2

Efficacy of single-site radiotherapy plus PD-1 inhibitors vs PD-1 inhibitors for oligometastatic non-small cell lung cancer.
Peiliang Wang, Tianwen Yin, Kaikai Zhao, Jinming Yu, Feifei Teng. J Cancer Res Clin Oncol 2022
0

Discontinuation of immune checkpoint inhibitor (ICI) above 18 months of treatment in real-life patients with advanced non-small cell lung cancer (NSCLC): INTEPI, a multicentric retrospective study.
Geoffroy Bilger, Nicolas Girard, Hélène Doubre, Matteo Giaj Levra, Etienne Giroux-Leprieur, Frederique Giraud, Chantal Decroisette, Matthieu Carton, Marie Ange Massiani. Cancer Immunol Immunother 2022
1

Rational administration sequencing of immunochemotherapy elicits powerful anti-tumor effect.
Chunqi Zhu, Yingying Shi, Qingpo Li, Lihua Luo, Xiang Li, Zhenyu Luo, Yichao Lu, Junlei Zhang, Mengshi Jiang, Bing Qin,[...]. J Control Release 2022
1

IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer.
O Molinier, B Besse, F Barlesi, C Audigier-Valette, S Friard, I Monnet, G Jeannin, J Mazières, J Cadranel, J Hureaux,[...]. ESMO Open 2022
1

Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study.
Mette T Mouritzen, Karen F Junker, Andreas Carus, Morten Ladekarl, Peter Meldgaard, Anders W M Nielsen, Anna Livbjerg, Jacob W Larsen, Halla Skuladottir, Charlotte Kristiansen,[...]. Acta Oncol 2022
2

The impact of gender on The efficacy of immune checkpoint inhibitors in cancer patients: The MOUSEION-01 study.
Matteo Santoni, Alessandro Rizzo, Veronica Mollica, Marc R Matrana, Matteo Rosellini, Luca Faloppi, Andrea Marchetti, Nicola Battelli, Francesco Massari. Crit Rev Oncol Hematol 2022
0

Effect of prior antibiotic or chemotherapy treatment on immunotherapy response in non-small cell lung cancer.
Andrew F Nyein, Shahla Bari, Stephanie Hogue, Yayi Zhao, Bradley Maller, Sybil Sha, Maria F Gomez, Dana E Rollison, Lary A Robinson. BMC Cancer 2022
0

Prognostic and Immunological Role of FAT Family Genes in Non-Small Cell Lung Cancer.
Zhenxing Feng, Yan Yin, Bin Liu, Yafang Zheng, Dongsheng Shi, Hong Zhang, Jianwen Qin. Cancer Control 2022
0

Neutrophil Extracellular Traps in Cancer Therapy Resistance.
Muhammad H Shahzad, Lixuan Feng, Xin Su, Ariane Brassard, Iqraa Dhoparee-Doomah, Lorenzo E Ferri, Jonathan D Spicer, Jonathan J Cools-Lartigue. Cancers (Basel) 2022
0

PD-1/L1 inhibitors may increase the risk of pericardial disease in non-small-cell lung cancer patients: a meta-analysis and systematic review.
Honglin Li, Deting Han, Lei Zhang, Xiaoteng Feng, Huijie Li, Feiran Yang, Lucheng Song, Xiurong Li. Immunotherapy 2022
0

A retrospective cohort study of sintilimab and pembrolizumab as first-line treatments for advanced non-small cell lung cancer.
Kai Wu, Yifan Fu, Daxiong Zeng, Tao Chen, Changguo Wang, Junhong Jiang. J Thorac Dis 2022
0

Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving Nivolumab.
Giulia Pasello, Martina Lorenzi, Lorenzo Calvetti, Cristina Oliani, Alberto Pavan, Adolfo Favaretto, Giovanni Palazzolo, Petros Giovanis, Fable Zustovich, Andrea Bonetti,[...]. Oncologist 2022
0


Efficacy and safety of sintilimab plus docetaxel in patients with previously treated advanced non-small cell lung cancer: a prospective, single-arm, phase II study in China.
Xiao Han, Jun Guo, Xiaoyong Tang, Hui Zhu, Dongyuan Zhu, Xiqin Zhang, Xiangjiao Meng, Ying Hua, Zhongtang Wang, Yan Zhang,[...]. J Cancer Res Clin Oncol 2022
1




PD-1 blockade therapy augments the antitumor effects of lymphodepletion and adoptive T cell transfer.
Miho Takahashi, Satoshi Watanabe, Ryo Suzuki, Masashi Arita, Ko Sato, Miyuki Sato, Yuki Sekiya, Yuko Abe, Toshiya Fujisaki, Aya Ohtsubo,[...]. Cancer Immunol Immunother 2022
0


The immune modifying effects of chemotherapy and advances in chemo-immunotherapy.
Daniel R Principe, Suneel D Kamath, Murray Korc, Hidayatullah G Munshi. Pharmacol Ther 2022
2

Inflammatory Thoracic Aortic Aneurysm in a Patient with Advanced Lung Adenocarcinoma Treated with Pembrolizumab.
Ryusuke Ninomiya, Yuhei Kinehara, Satoshi Tobita, Hachiro Konaka, Ryu Jokoji, Takashi Shintani, Isao Tachibana. Intern Med 2022
0

Chemoimmunotherapy for EGFR-Mutant NSCLC: Still No Clear Answer.
Bharathi Muthusamy, Nathan Pennell. J Thorac Oncol 2022
1

Generalizability of immune checkpoint inhibitor trials to real-world patients with advanced non-small cell lung cancer.
Monica Tang, Chee K Lee, Craig R Lewis, Michael Boyer, Bernadette Brown, Andrea Schaffer, Sallie-Anne Pearson, Robert J Simes. Lung Cancer 2022
0